Our emails have transitioned to the Revvity.com domain, however our billing information is unchanged. Click for details.
Register to view:

Efficient multigene targeting in primary T cells with CRISPRa, CRISPRi mRNA, and synthetic guide RNAs

This application note demonstrates the utility and feasibility of targeting multiple genes simultaneously with CRISPRa and CRISPRi.

Please fill the simple form on the right to download this application note.

Required fields marked with *(Required)

By submitting my personal data, I acknowledge that Revvity, Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy (available here).